Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Income from Continuing Operations (2018 - 2025)

TELA Bio has reported Income from Continuing Operations over the past 8 years, most recently at 30260000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 30260000.0 for Q4 2025, up 3.46% from a year ago — trailing twelve months through Dec 2025 was 470000.0 (down 23.58% YoY), and the annual figure for FY2025 was 470000.0, down 38.08%.
  • Income from Continuing Operations for Q4 2025 was 30260000.0 at TELA Bio, up from 8603000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for TELA hit a ceiling of 30260000.0 in Q4 2025 and a floor of 13623000.0 in Q4 2023.
  • Median Income from Continuing Operations over the past 5 years was 10445500.0 (2022), compared with a mean of 6215950.0.
  • Biggest five-year swings in Income from Continuing Operations: soared 314.7% in 2024 and later plummeted 98.98% in 2025.
  • TELA Bio's Income from Continuing Operations stood at 8576000.0 in 2021, then decreased by 23.75% to 10613000.0 in 2022, then dropped by 28.36% to 13623000.0 in 2023, then surged by 314.7% to 29248000.0 in 2024, then grew by 3.46% to 30260000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 30260000.0 (Q4 2025), 8603000.0 (Q3 2025), and 9923000.0 (Q2 2025) per Business Quant data.